Neutral
Whitefort outlines 8.1% Arbutus Biopharma (ABUS) stake in amended 13D
Whitefort Capital and its related entities have reported an 8.1% beneficial ownership in Arbutus Biopharma (ABUS), acquiring 15,794,261 common shares ...